Austin Cancer Center is always searching for the next great advancement in cancer treatment. Clinical trials play an important role in determining better and safer medical treatments as well as improving quality of life for patients. We currently offer research trials in breast, solid tumor, and radiation therapy. See details below to learn more about the current trials available with Austin Cancer Center:
- Phase III Randomized Study of Standard versus Accelerated Hypofractionated Image-Guided Radiation Therapy (IGRT) in the Definitive Setting for Patients with Stage II-III orRecurrent Non-Small Cell Lung Cancer and Poor Performance Status. PI: Angel Rodriguez, MD
- Sophia Study CP: MGAH22-04A Phase 3, Randomized Study of Margetuximab PlusChemotherapy vs Trastuzumab Plus Chemotherapy in thetreatment of patients with HER2+ Metastatic Breast Cancerwho have received prior Anti-HER2 Therapies and require Systemic Treatment. http://www.sophiambc.com PI: Angel Rodriguez, MD
- Observational Registry: This is a prospective, observational, case-only study linking molecular genomic test, circulating tumor molecular profiles or high resolution advanced imaging results to treatment response, recurrence free survival (RFS), and distant metastases free survival (DMFS) in patients who have been diagnosed with breast cancer and who are treated with neo-adjuvant therapy. PI: Jane Nelson, MD
- CanScript/MitraBiotech: This is an observational data collection study evaluating how physicians utilize therapeutic sensitivity information ascertained with CANscript, and subsequently describing clinical outcomes. PI: Rachel Brightwell, MD
If you are interested in any of the trials listed on this page, please contact our clinical research coordinator Luisa Sansalone at firstname.lastname@example.org.
To participate in a trial is voluntary and can be discussed with your physician.